Monoclonal Antibodies Production Platforms: An Opportunity Study of a Non‐Protein‐A Chromatographic Platform Based on Process Economics

Monoclonal antibodies currently dominate the biopharmaceutical market with growing sales having reached 80 billion USD in 2016. As most top‐selling mAbs are approaching the end of their patent life, biopharmaceutical companies compete fiercely in the biosimilars market. These two factors present a s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biotechnology journal 2017-12, Vol.12 (12), p.n/a
Hauptverfasser: Grilo, António L., Mateus, Marília, Aires‐Barros, Maria R., Azevedo, Ana M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!